Patients

Five things for pharma marketers to know: Thursday, September 29, 2016

Five things for pharma marketers to know: Thursday, September 29, 2016

By

Sharecare acquires virtual-reality developer; Novo Nordisk to cut 1,000 jobs; the FDA approves Medtronic's automated insulin pump

Why Any Merger is the Last Resort of Lousy Marketers

Why Any Merger is the Last Resort of Lousy Marketers

By

Really? Is this the new healthcare math — the fewer the insurance companies, the greater the competition and the lower the premiums?

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

By

The latest TV campaign from Mars features a woman with cerebral palsy joking about her love life.

Infographic: How physicians share online info with patients and other docs

Infographic: How physicians share online info with patients and other docs

The availability of online medical information is changing the way doctors share and receive information — both among themselves and with their patients.

The co-pay card debate simmers, as payers push back

The co-pay card debate simmers, as payers push back

By

Will this payer pressure pose an existential threat to co-pay cards even though patients love them?

How Insights from Patients Can Shape Medical Practice and Communication

How Insights from Patients Can Shape Medical Practice and Communication

Many patients find it difficult to ask questions of their physician.

Patient-Centricity: There's Always Room for Improvement

Patient-Centricity: There's Always Room for Improvement

It's unlikely that pharma will ever achieve the degree of consumer love directed at Amazon and Apple but the shift taking place will open up doors for pharma organizations.

Hacking Healthcare: Will It Help the Patient?

Hacking Healthcare: Will It Help the Patient?

The power of hackathons is now magnified because of the power of the internet and social media, giving both patients and healthcare professionals a global platform for their voices.

Patient Listening: Is Pharma Doing It Right?

Patient Listening: Is Pharma Doing It Right?

Imagine if the agencies pitching us mocha lattes faced these consumer beliefs: The latte will hurt when I drink it. The latte might leave me with a rash or cause me to vomit.

5 Keys to Success in the New Patient Economy

5 Keys to Success in the New Patient Economy

In the webinar, 5 Keys to Success in the New Patient Economy, you'll learn tips and strategies for transforming your patient engagement model.

What pharma brands can learn from Lions Health

What pharma brands can learn from Lions Health

By

Drugmakers test out virtual reality, partner with companies like Spotify, and go for the cinematic at Cannes Lions.

The CIO, reimagined for pharma

The CIO, reimagined for pharma

By

Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.

Leadership Exchange: Engaging the Millennial Doctor

Leadership Exchange: Engaging the Millennial Doctor

By

In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.

From the Editor: The Patient Journey 2016

From the Editor: The Patient Journey 2016

By

The truth is, biopharma marketing and behavioral psychology have a lot in common. Ultimately, both aim to nudge people to make a medical or lifestyle change that could positively impact their health.

The Science and Psychology behind Patient Engagement

The Science and Psychology behind Patient Engagement

Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?

4 trends with the potential to change behavior in the patient journey

4 trends with the potential to change behavior in the patient journey

By

It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.

The Marketer's Role is To Be the Voice of the Patient

The Marketer's Role is To Be the Voice of the Patient

Maybe we have just forgotten the true reason why marketing exists in organizations.

An emotional bond with patients is key, says Elemental Machines' Iyengar

An emotional bond with patients is key, says Elemental Machines' Iyengar

By

At the MM&M Transforming Healthcare conference, Iyengar told attendees how to take into account a consumer's behavior and emotion when marketing medical products.

Is virtual reality the ultimate emotive storytelling tool?

Is virtual reality the ultimate emotive storytelling tool?

By

Wieden+Kennedy Portland's VR work for the National Multiple Sclerosis Society lets wheelchair-bound patients experience their favorite activities again, like dancing or surfing.

Infographic: Better promotion of clinical trials

Infographic: Better promotion of clinical trials

Companies spend $2 billion per year recruiting patients for clinical trials. A survey of 702 adults, conducted from December 2015 to January 2016, points to a need for more awareness.

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

By

Monique Levy, who's spent more than a decade helping drugmakers understand technology shifts, has joined PatientsLikeMe, the online discussion platform for people with chronic illness.

Balancing Opportunity and Responsibility in Healthcare Targeting

Balancing Opportunity and Responsibility in Healthcare Targeting

If you truly understand who your high writers and compliant patients are, you'll understand when and how to communicate with prospects that look and act like them.

No More 'Patient-Centric,' Please

No More 'Patient-Centric,' Please

By

Maybe it's time for pharma and healthcare marketers to put all the "patient-centric" talk on the shelf — not the actual paying-attention-to-patients part of it, but the trumpeting of it as the most noble of life-science virtues.

How My GI Health changed the conversation for patients

How My GI Health changed the conversation for patients

By

The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.

Ironwood's McCourt bets big on data and the patient-physician dialogue

Ironwood's McCourt bets big on data and the patient-physician dialogue

By

Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.

The truth about a doctor's day: know-it-all patients and no time for lunch

The truth about a doctor's day: know-it-all patients and no time for lunch

By

There are big changes underway in the doctor-patient relationship, a study suggests, and it's a new reality to which biopharma must adjust.

Five things for pharma marketers to know: Tuesday, March 1, 2016

Five things for pharma marketers to know: Tuesday, March 1, 2016

By

Analysis questions Addyi's effectiveness; Horizon is subpoenaed about its patient assistance programs; AstraZeneca sells non-U.S. rights to constipation drug

OPINION

Email Newsletters